NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 78 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2015. The put-call ratio across all filers is 97.39 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,000 | 0.0% | 3,472 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 3,472 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 3,472 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 3,472 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | -50.0% | 3,472 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $2,000 | 0.0% | 3,472 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,000 | -33.3% | 3,472 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $3,000 | +50.0% | 3,472 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $2,000 | -33.3% | 3,472 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $3,000 | -40.0% | 3,472 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $5,000 | -37.5% | 3,472 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $8,000 | +33.3% | 3,472 | 0.0% | 0.00% | +33.3% |
| Q2 2015 | $6,000 | – | 3,472 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |